Putnam Investments LLC Jounce Therapeutics, Inc. Transaction History

Putnam Investments LLC

  • $73 Billion
  • Q4 2023

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022
SELL
$2.8 - $7.67 $143,136 - $392,090
-51,120 Closed
0 $0
Q1 2022

May 16, 2022
SELL
$6.01 - $8.54 $22,519 - $31,999
-3,747 Reduced 6.83%
51,120 $347,000
Q4 2021

Feb 14, 2022
BUY
$7.11 - $9.64 $390,104 - $528,917
54,867 New
54,867 $458,000

Others Institutions Holding JNCE

# of Institutions
4
Shares Held
720K
Call Options Held
0
Put Options Held
0
View Full List

About Jounce Therapeutics, Inc.

JNCE Quotes by TradingView
  • Ticker JNCE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 51,694,200
  • Description
  • Jounce Therapeutics, Inc., a clinical-stage immunotherapy company, develops therapies for the treatment of cancer. The company develops vopratelimab, a clinical-stage monoclonal antibody, which is in Phase II clinical trial that binds to and activates the Inducible T cell CO-Stimulator, a protein on the surface of T cells found in various solid ...
More about JNCE
Track This Portfolio

Track Putnam Investments LLC Portfolio

Follow Putnam Investments LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Putnam Investments LLC, based on Form 13F filings with the SEC.

News

Stay updated on Putnam Investments LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email